Overall for GDM, 2 h-OGTT, gestational age at birth, neonatal hypoglycemia outcomes the heterogeneity was high, while for insulin therapy, C-section rate, neonatal intensive care unit admission, preterm birth, shoulder dystocia and gestational hypertension outcomes, it was low. This evidence concerns the gene INS and gestational diabetes.